Core Viewpoint - Nanjing Bank has announced the early redemption of its convertible bond, Nan Yin Convertible Bond, due to the triggering of conditional redemption clauses, reflecting a strong performance in the banking sector and a trend of multiple banks' convertible bonds being redeemed early [1][3][4]. Group 1: Convertible Bonds Redemption - Nanjing Bank's stock price has been above 130% of the conversion price of 8.22 CNY per share for 15 out of 19 trading days, leading to the decision to exercise the early redemption right [3]. - Other banks, including Suzhou Bank and Hangzhou Bank, have also seen their convertible bonds trigger early redemption this year, indicating a broader trend in the banking sector [2][4]. - The Hangzhou Bank's convertible bond was also recently announced for early redemption, with its stock price exceeding 130% of the conversion price of 11.35 CNY per share [4]. Group 2: Market Supply and Demand - The market is currently facing a short-term supply shortage of bank convertible bonds, as no new bank convertible bonds have been issued recently, leading to potential price increases for existing bonds [4]. - As of now, there are 10 bank convertible bonds in the market, with the Shanghai Pudong Development Bank's bond set to mature on October 28, 2025, with an issuance scale of 50 billion CNY [4]. Group 3: Banking Sector Performance - The banking sector has shown strong performance, with multiple bank stocks reaching new highs, contributing to the favorable conditions for convertible bond redemptions [5]. - Analysts remain optimistic about the absolute value of bank stocks, citing historical stability in returns during the traditional dividend distribution period in June and July [6]. - Long-term policies aimed at stabilizing the economy and promoting consumption are expected to benefit the banking sector, with continued demand from institutional investors [6].

Investment Rating - The investment rating for Bank of Nanjing is maintained at BUY with a target price of RMB 13.29, indicating a potential upside of 17% from the closing price of RMB 11.35 as of 9 June 2025 [1][6]. Core Insights - The conditional redemption clause of the convertible bonds (CBs) has been triggered, which is expected to enhance the capital strength of Bank of Nanjing and support further business expansion [2]. - The unconverted balance of the CBs is approximately RMB 5.2 billion, accounting for about 4% of the company's total market capitalization, suggesting limited share-capital dilution while maintaining a solid dividend profile and growth potential [3]. - Bank of Nanjing has demonstrated steady earnings growth, with a year-on-year increase in revenue and net profit of 6.5% and 7.1% respectively in 1Q25, outperforming peers [4]. Financial Performance - Revenue is projected to grow from RMB 45,160 million in 2023 to RMB 61,209 million by 2027, with a compound annual growth rate (CAGR) of approximately 7.27% [12]. - Net profit attributed to the parent is expected to increase from RMB 18,502 million in 2023 to RMB 26,113 million in 2027, reflecting a steady growth trajectory [12]. - The estimated dividend yield for 2025 is 5.02%, which remains attractive even after accounting for potential dilution from the CB conversion [3][12]. Valuation Metrics - The forecasted earnings per share (EPS) for 2025 is RMB 1.86, with a price-to-earnings (PE) ratio of 6.10x, indicating a favorable valuation compared to peers [10][12]. - The book value per share (BVPS) is estimated at RMB 14.77 for 2025, with a price-to-book (PB) ratio of 0.77x, suggesting that the stock is undervalued relative to its intrinsic value [10][12]. - The core capital adequacy ratio is expected to improve by 0.57 percentage points to 9.46% following the full conversion of the CBs, enhancing the bank's capital position [2].

近日，南京银行公告，该行发行的"南银转债"已触发有条件赎回条款，该行决定行使 "南银转债"的 提前赎回权。这也意味着，在银行股涨势持续下，年内已有多只银行可转债触发强赎，包括苏行转 债、杭银转债等。 最新触发强赎的为杭银转债，5月26日，杭州银行公告，自2025年4月29日至2025年5月26日，该公司股票已有 15个交易日的收盘价不低于杭银转债当期转股价格11.35元/股的130%（含130%，即不低于14.76元/股），根据 相关约定，已触发杭银转债的有条件赎回条款，该行决定行使杭银转债的提前赎回权。 Wind数据显示，截至今日，市场共有浦发转债、紫银转债、兴业转债等10只银行转债，其中，浦发转债即将 于10月28日到期，发行规模为500亿元。业内人士预测，随着杭银转债、南银转债等接连触发强赎，同时近年 来再无新发银行可转债进入市场，短时间内市场供不应求，相关标的价格或将上涨。 银行股"涨"声一片 可转债接连触发强赎，得益于年内银行板块持续飘红。 6月10日，多只银行股保持上涨态势，其中，江苏银行、南京银行、兴业银行、北京银行、长沙银行、成都银 行、中信银行股价创新高。 多只可转债接连官宣 根据南京银行公 ...

| 证券代码：601009 | | 证券简称：南京银行 | 公告编号：2025-023 | | --- | --- | --- | --- | | 优先股简称：南银优 1 | | | 优先股代码：360019 | | 2 | 南银优 | | 360024 | | 可转债简称：南银转债 | | | 可转债代码：113050 | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌 期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | 113050 | 南银转债 | 可转债转股停 | 2025/6/16 | | | | | | | 牌 | | | | | 南京银行股份有限公司 关于实施 2024 年度权益分派时"南银转债" 转股连续停牌的提示性公告 因公司实施 2024 年度权益分派,公司的相关证券停复牌情况如下：自本次普 通股权益分派实施公告前一交易日（ ...

Core Viewpoint - The banking sector continues to show resilience and strength, with many bank stocks reaching new highs despite broader market adjustments, driven by high dividend yields and institutional investment interest [1][2][4]. Group 1: Bank Stock Performance - On June 10, bank stocks performed strongly, with the China Securities Bank Index reaching a high of 7916.59 points before closing up 0.49% [1][2]. - A total of 39 out of 42 bank stocks rose, with notable gains from Minsheng Bank and Zheshang Bank, which increased by 2.83% and 2.14%, respectively [2]. - The banking sector has shown a year-to-date performance ranking among the top four industries, with 21 bank stocks rising over 10% and 7 over 20% [2]. Group 2: Dividend Strategies - The median dividend yield for banks remains attractive at over 4%, with many banks announcing earlier dividend distributions compared to previous years [3]. - As of now, 17 banks have announced their year-end dividend plans, with 12 already implemented [3]. - The traditional dividend distribution period in June and July is expected to have a stable overall performance, with historical data showing positive absolute and relative returns during this period [3][4]. Group 3: Convertible Bonds - The rise in bank stock prices has led to an acceleration in the exit of bank convertible bonds from the market, with Nanjing Bank's convertible bond triggering mandatory redemption conditions [1][6]. - Nanjing Bank's convertible bond, with a total amount of 20 billion yuan, has seen its conversion rate increase from approximately 47.6% to over 75% [8]. - The overall market for bank convertible bonds is expected to shrink significantly, with predictions indicating a reduction from 1.7 billion yuan to around 1 billion yuan due to several bonds triggering early redemption [8].

| 证券代码：601009 | | 证券简称：南京银行 | 公告编号：2025-023 | | --- | --- | --- | --- | | 优先股简称：南银优 1 | | | 优先股代码：360019 | | 2 | 南银优 | | 360024 | | 可转债简称：南银转债 | | | 可转债代码：113050 | 南京银行股份有限公司 关于实施 2024 年度权益分派时"南银转债" 转股连续停牌的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因公司实施 2024 年度权益分派,公司的相关证券停复牌情况如下：自本次普 通股权益分派实施公告前一交易日（2025 年 6 月 16 日）至权益分派股权登记日期 间，"南银转债"将停止转股；本次权益分派股权登记日后的第一个交易日，"南 银转债"恢复转股。欲享受公司本次权益分派的"南银转债"持有人可于 2025 年 6 月 13 日（含当日）前转股。 | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌 期间 ...

10日，A股、港股午后全线回落，创业板指、科创50指数等跌超1%，恒生科技指数跌近1%。 具体来看，两市股指早盘窄幅震荡，午后加速下探。截至收盘，沪指跌0.44%报3384.82点，深证成指跌0.86% 报10162.18点，创业板指跌1.17%报2037.27点，科创50指数跌1.47%，北证50指数跌约1%，沪深北三市合计成 交14516亿元，较此前一日增加近1400亿元。 场内超4000股飘绿，半导体、军工、石油、券商、酿酒等板块走低；银行板块走强，民生银行一度涨约4%， 兴业银行、南京银行盘中创出新高；农业板块拉升，种业股表现亮眼，秋乐种业、康农种业涨超10%；离境退 税概念崛起，国航远洋30%涨停，宁波海运、南京港、连云港等涨停；创新药概念再度活跃，昂利康连续3日 涨停，一品红、泰恩康涨超9%均创出新高；稀土概念持续强势，中科磁业、科恒股份等涨停；短剧概念尾盘 异动，中文在线涨超13%，慈文传媒涨停；体育概念热度不减，共创草坪斩获7连板。 离境退税概念盘中大幅走高，截至收盘，国航远洋30%涨停，华光源海涨近27%，宁波远洋、南京港、连云港 等均涨停。 | 代码 | 名称 | 4 | 涨幅% | 现价 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ A股三大股指6月10日开盘涨跌互现。早盘指数分化，沪指在银行股走强下表现较强。午后两市快速下 挫，沪指更是一度跌1%。 从盘面上看，TMT行业全线调整，半导体、算力、AI应用、金融科技、消费电子概念股跌幅靠前。离 境退税、稀土永磁、种业题材午后逆势上涨；新消费、创新药概念股活跃。 至收盘，上证综指跌0.44%，报3384.82点；科创50指数跌1.47%，报982.9点；深证成指跌0.86%，报 10162.18点；创业板指跌1.17%，报2037.27点。 Wind统计显示，两市及北交所共1260只股票上涨，4034只股票下跌，平盘有118只股票。 沪深两市成交总额14153亿元，较前一交易日的12864亿元增加1289亿元。其中，沪市成交5574亿元，比 上一交易日5119亿元增加455亿元，深市成交8579亿元。 两市及北交所共有79只股票涨幅在9%以上，10只股票跌幅在9%以上。 计算机板块领跌两市，退市龙宇（维权）（603003）跌超30%，新致软件（688590）、中科信息 （300678）、慧博云通（301316）、石基信 ...

Market Overview - The A-share market showed a narrow range of consolidation on June 10, with the Shanghai Composite Index rising by 0.11% to 3403.52 points, while the Shenzhen Component Index fell by 0.23% and the ChiNext Index decreased by 0.36% [1] - The total trading volume for the A-share market reached 808.39 billion yuan [1] Monetary Policy - The People's Bank of China conducted a 7-day reverse repurchase operation of 198.6 billion yuan at a fixed rate of 1.40%, with a total bid amount matching the operation amount [2] - A net withdrawal of 255.9 billion yuan was calculated for the day, considering that 454.5 billion yuan in reverse repos matured [2] Social Welfare Initiatives - The Ministry of Finance announced increased subsidies and nationwide coordination of pension insurance, benefiting over 300 million elderly individuals [3] - The Ministry of Education plans to address the shortage of high school seats by constructing or renovating over 1000 quality high schools and aims for standardized construction of compulsory education schools within five years [3] Sector Performance - Pharmaceutical stocks showed strong performance, particularly in the CRO and innovative drug sectors, with companies like Angli Kang and ZHONGSHENG Pharmaceutical hitting the daily limit [3] - Banking stocks also saw gains, with Chengdu Bank and Nanjing Bank reaching historical highs during trading [3] Weight Loss Drug Sector - The WHO has been developing new guidelines for obesity prevention and treatment since 2022, which includes the clinical indications and applications of GLP-1 drugs, potentially standardizing their use in weight management [4] - The weight loss drug sector is gaining attention, with GLP-1 drugs expected to see increased application among weight loss populations [4] Company Insights - Hanyu Pharmaceutical is transitioning from a domestic to a global enterprise, planning to launch nearly 20 peptide and small nucleic acid drugs overseas in the next decade, focusing on weight loss and diabetes [7] - Zhongsheng Pharmaceutical has become the only domestic company with both COVID-19 and influenza innovative drugs, aiming to enhance its market position in respiratory medications [8] - Kexing Pharmaceutical is preparing for the domestic approval of a biosimilar of semaglutide by 2025 and is expanding its overseas business through strategic partnerships [9] - Yipin Hong is focusing on innovation, with promising clinical data for AR882, which has the potential to be a best-in-class product [9]

证券研究报告 南京银行 (601009 CH) | 华泰研究 | | | 动态点评 | | --- | --- | --- | --- | | 2025 年 | 6 月 | 10 日│中国内地 | 区域性银行 | 2025 年 6 月 9 日，南京银行公告称已触发"南银转债"有条件赎回条款。 公司植根江苏优质区域，盈利稳健增长，分红比例保持较高水平，是兼具成 长潜力的股息标的，去年以来股东多次增持彰显发展信心。可转债强赎价附 近博弈阻力加剧，年初以来南京银行涨幅落后可比同业，估值仍有修复潜力。 转股完成后有望夯实公司资本，打开业务拓展空间，维持买入评级。 转债触发强赎，夯实公司资本 公司公告称自 2025 年 5 月 13 日至 2025 年 6 月 9 日期间，已有 15 个交易 日收盘价不低于"南银转债"当期转股价格 8.22 元/股的 130%（含 130%）， 即 10.69 元/股，已触发"南银转债"的有条件赎回条款。本次可转债提前 赎回完成后，将增强公司的资本实力，为业务进一步扩张提供支撑。25Q1 末南银转债未转股余额 105 亿元，以 25Q1 末风险加权资产静态测算，转股 完成后将提升核充率 ...